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Selective  T3–T4 sympathicotomy 
versus gray ramicotomy 
on outcome and quality of life 
in hyperhidrosis patients: 
a randomized clinical trial
Vicente Vanaclocha1,7*, Ricardo Guijarro‑Jorge2,7, Nieves Saiz‑Sapena3,7, 
Manuel Granell‑Gil3,7, José María Ortiz‑Criado4,7, Juan Manuel Mascarós5,7 & 
Leyre Vanaclocha6,7
Compensatory hyperhidrosis is the leading cause of patients’ dissatisfaction after thoracic 
sympathicotomy. The study aimed to reduce compensatory hyperhidrosis to increase patients’ 
satisfaction. A prospective randomized study on palmar hyperhidrosis, May 2016–September 2019. 
Twenty‑one patients  T3–T4 sympathicotomy and 21  T3–T4 gray ramicotomy. Data prospectively 
collected. Analysis at study’s end. Focus on the sweating, temperature, quality of life baseline and 
postoperatively, compensatory hyperhidrosis, hand dryness, patients’ satisfaction, and if they 
would undergo the procedure again and recommend it. No baseline differences between groups. 
Hyperhidrosis was controlled postoperatively in all patients. No mortality, serious complications, or 
recurrences. Sympathicotomy worse postoperative quality of life (49.05 (SD: 15.66, IR: 35.50–63.00) 
versus ramicotomy 24.30 (SD: 6.02, IR: 19.75–27.25). After ramicotomy, some residual sweating on 
the face, hands, and axillae. Compensatory sweating worse with sympathicotomy. Satisfaction higher 
with ramicotomy. Better results with ramicotomy than sympathicotomy regarding hand dryness, how 
many times a day the patients had to shower or change clothes, intention to undergo the procedure 
again or recommend it to somebody else, and how bothersome compensatory hyperhidrosis was.  T3–
T4 gray ramicotomy had better results than  T3–T4 sympathicotomy, with less compensatory sweating 
and higher patients’ satisfaction.
Hyperhidrosis is a sympathetic nervous system dysfunction in which there is sweating beyond physiologi-
cal  needs1. It affects mainly the hands and  axillae2, making social interaction  difficult3. Medical treatments 
are  helpful4,5, but thoracic sympathectomy (TS) is used in refractory  cases6,7. Although practised since 1920 8, 
continuous improvements over the years have led to a progressive reduction in aggressiveness, morbidity, and 
mortality of  TS6,7.
Just after the TS patients are pleased as they do not longer sweat in the areas where it was incredibly cum-
bersome (hands and axillae)9, but as time goes by, especially during the summer, they notice sweating in areas 
that did not sweat before or not to such an extent, such as the abdomen, torso, buttocks, and  thighs10. This new 
sweating is known as compensatory hyperhidrosis (CH) and is the fundamental cause of long-term patients’ 
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 dissatisfaction11–13. Another problem, although patients do not complain so often about  it14, is the over-dryness 
of the sympathetically denervated area (head/face, hands, and axillae)15,16.
Removal of the sympathetic chain is no longer  advocated17,18. Instead, this chain’s surgical section, known as 
sympathicotomy (SY), is commonplace at different  levels19–21. However, this leaves the axillae, hands, face, and 
head with no possibility of sweating and temperature  regulation22,23. It has to be kept in mind that this area, the 
upper part of the body, represents 40% of the area through which we control our temperature by heat dissipa-
tion through  sweating24.
Over time the extent of sympathetic chain surgical lesion has been decreased, attempting to reduce the 
incidence and severity of  CH25,26. Many agree that the number of sympathetic ganglia injured should include 
only  T3 and  T418,27–29.
Some have tried applying clips instead of irreversibly damaging the nervous  tissue30. In bothersome CH, 
these clips can be removed and wait to hope for  improvement31. Unfortunately, this is not always the  case32,33.
Attempting further refinement, surgeons lesioned only the white and gray rami communicantes (RC) without 
injuring the sympathetic chain  itself34. This surgical technique reduced CH severity, but its incidence remained 
 unaltered35.
Some recent studies have tried to lesion only the gray rami communicantes, leaving the white rami commu-
nicantes and sympathetic chain  intact36,37. Both studies showed a further reduction in the incidence and severity 
of CH, but the number of treated levels seemed excessive  (T2–T5 for Akil et al.36 and  T2–T4 for Coveliers et al.37).
We hypothesized that the selective lesion of the gray  T3 and  T4 rami communicantes would be enough to 
reduce CH incidence and severity. In addition, this selective sympathetic system lesion should improve the 
patients’ satisfaction and reduce excessive dry hands, gustatory sweating, and cardio-pulmonary disorders (feel-
ing of lack of strength when trying to lift a weight).
Patients and methods
Study population. We obtained Ethical and Research Committees’ approval, and we performed all meth-
ods following the relevant guidelines and regulations following the Helsinki Declaration rules. Clinical registra-
tion number CEIm 24-02-2016 (Comité de Ética e Investigación), date of approval 24/02/2016, ClinicalTrials.
gov Identifier: NCT04721483, date of registration 22/01/2021.
We conducted this study between May 2016 and September 2019, including forty-two patients distributed 
in a prospective randomized fashion between two groups (Supplementary figure S1). We calculated the sample 
size based on previous research and used a block randomization model. We took eight blocks of four and two 
blocks of five patients with a random distribution of two patients from each group. This project was blind (only 
the surgeons knew which group the patients belonged to). A team member collected the data, unaware of which 
specific surgical procedure had undergone each patient. The procedure was a classical  T3–T4 SY in twenty-one 
patients and a selective  T3–T4 gray RC lesion in the other twenty-one.
Dermatology referred the patients to us once all conservative treatments proved inefficient or the patient 
refused to continue with them. Unfortunately, seven patients declined to participate in this study.
Data were prospectively collected and analyzed at the end of the study. We focused on the surgical proce-
dures’ duration, the length of the hospital stays, the amount and severity of complications, and the sweating and 
temperature before and after the surgical procedure. We likewise recorded the intraoperative temperature rise in 
the hands, the quality of life baseline and on follow-ups, as well as the CH. We also registered how many times 
patients had to shower or change clothes, hand dryness, hand moisturizer, and satisfaction with the results. In 
addition, we asked patients if they would undergo the same procedure again and recommend it to somebody 
else. Finally, we measured postoperative B.M.I. changes as they might impact  outcomes38.
All patients suffered from palmar, axillary, and plantar HH, but the main reason to seek surgical treatment 
was excessive palmar sweating.
We documented informed consent for each patient, where patients agreed to be allocated randomly to either 
group and attend follow-up appointments.
The minimum postoperative follow-up required for patients included in our study was 12 months.
A member not participating in the patients’ care collected the data.
Inclusion criteria. Age 18–60 years, palmar HH with or without axillary HH refractive to conservative treat-
ments or reluctant to continue with them after six months and willing to undergo surgical treatment, Hyperhi-
drosis Disease Severity Score grade  D39.
Exclusion criteria. Previous thoracic pathology (lung infections, particularly pulmonary empyema, pneumo-
thorax, hemothorax, rib fractures, neoplasms), heart failure, hypothyroidism, tuberculosis, bradycardia (40 pul-
sations/min), alcoholism, drug addiction, BMI > 30, pregnancy, generalized HH or related to any health disor-
der, comorbidities or medication intake that induce excessive sweating. We excluded patients with primary facial 
or plantar HH and those not complying with follow-ups.
Baseline patients’ evaluation. On their first consultation and at each follow-up appointment, patients 
fulfilled the quality of life questionnaire developed by Amir et al.40 (Supplementary table S1). We asked patients 
not to use any ointment, cream on the skin, or do physical exercise before the evaluation. We recorded baseline 
sweating and skin temperature at the forehead, palms of hands, axillae, abdomen, thighs, and soles of feet. We 
placed patients in a closed room for 15 min at 25 °C and 60% humidity (SAIVOD, Shenzhen, China). We col-
lected the sweat with an absorbent pad (DELIPLUS, Mercadona, Paterna, Valencia, Spain). We recorded each 
absorbent pad’s using a precision scale (GRAM FH 6000, Gram Precision S.L., l’Hospitalet de Llobregat, Barce-
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lona, Spain) before and 15 min after being placed in the corresponding anatomical area. The increase in weight 
corresponded to the sweat produced. We measured the temperature with a laser thermometer (QUIRUMED 
574-300, HuBDIC Co., Ltd., Anyang-si, Gyeonggi-do, Korea).
Surgical procedure. Step 1. Patients underwent general anaesthesia with double-lumen endotracheal in-
tubation (VYGON US, Montgomeryville, PA, USA). We inserted intradermal electrodes (MTS-400010, Level 
Myocardial Temperature Sensor, Smiths Medical ASD, Inc., Rockland, MA 02370 USA) in the thenar eminenc-
es. We placed patients in the semi-Fowler position with the arms abducted 45°.
We used a thoracoscope (Storz code 26034AV, Karl Storz Endoscope, Tüttlingen, Germany).
The camera we used was a TELECAM (Storz code 20212030, Karl Storz Endoscope, Tüttlingen, Germany). 
The TV monitor was a TELE PACK X LED (Karl Storz Endoscope, Tüttlingen, Germany). The optic employed 
had a bayonet shape, allowing the introduction of pincers, scissors, or a right-angle hook.
After lung collapse, we inserted two portals (THORACIC TROCAR 13 mm/7 cm, Unimax Medical Systems 
Inc., Hsin Tien, Taipei, Taiwan) at the third intercostal space midaxillary line.
On inserting the portals, the lungs collapsed. Only four patients (4 lungs) required 600–1000 ml of  CO2 gas 
insufflation to induce a pneumothorax.
We inspected the pleural cavity and sectioned any adhesions. We undertook a thorough examination to 
identify the ganglia and the gray RC at  T3 and  T4.
Step 2. At this moment, patients underwent a  T3 and  T4 SY (Step 3A) or a  T3 and  T4 gray ramicotomy (RY) 
(Step 3B).
We opened the parietal pleural 5 mm lateral to the sympathetic chain with an "L" tip monopolar electrode 
(Storz code 26778 F, Karl Storz Endoscope, Tüttlingen, Germany). Then, we dissected with endoscopic Metzen-
baum scissors (34421 MS, Karl Storz Endoscope, Tüttlingen, Germany).
Step 3A: T3 and T4 sympathicotomy. The sympathetic chains were interrupted at the third and fourth ribs with 
harmonic scissors (Harmonic Scissors ACE7® + Laparoscopic Shears HARH45, Ethicon Endo-Surgery, Cincin-
nati, OH, 45242–2839 USA). We used a harmonic scalpel instead of a monopolar scalpel to achieve a more selec-
tive  lesion41,42. Bleeding from any nearby vessels was controlled by clip application.
Step 3B: T3 and T4 selective gray ramicotomy. We only dissected free the T3 and T4 gray RC in this group, leav-
ing the white RC, sympathetic chain, and ganglia untouched.
Once isolated, we sectioned the gray RC with harmonic scissors. We coagulated the pleura over the third and 
fourth ribs over 2 cm to ensure that we had sectioned all gray RC or Kuntz’s nerves. The sympathetic chain was 
not dissected or elevated from the ribs to avoid damaging it, its ganglia, or the white RC.
Intraoperative outcome measures. Intraoperative ablation of the sympathetic system was suspected 
with the change in the pulse oximeter amplitude, indicating increased hand blood circulation reported by other 
 researchers43. We used a rise of 0.8 °C or higher to confirm the sympathetic system interruption intraoperatively, 
as published by other researcher  groups37,44–46.
Step 4: Closure. Once we completed the elected sympathetic nervous system lesion, we inspected the pleural 
cavity. On inserting a 14-French tube, we applied suction to the pleural cavity to remove all the air and  CO2, the 
lung re-expanded, and the anaesthetist used a Valsalva equivalent manoeuvre. Next, we removed the 14-French 
thoracic tube under positive end-expiratory pressure. A tight subcutaneous purse-string suture ensured air-
tight sealing, and we closed the skin with an intracutaneous suture. Before discontinuing general anaesthesia, 
we obtained an anteroposterior plain chest radiograph with the patient in the Fowler position to confirm the 
absence of any pneumothorax.
Postoperative hospital stay and care. Postoperatively patients used an incentive spirometer to enhance 
pulmonary re-expansion. Discharge from the hospital took usually place the day after surgery. We advised 
patients to return to everyday daily life within 3–7 days and avoid intense physical activity for 15 days.
Follow‑up. One month postoperatively, we measured the sweating and temperature in the same manner and 
anatomical areas again. In addition, we requested patients complete the same quality of life scale form as fulfilled 
preoperatively plus a specific postoperative form developed by us (Table 1). These same studies and question-
naires were re-recorded in all follow-ups, at one year postoperatively and in July past the first postoperative year. 
Afterwards, patients had yearly follow-ups.
Outcome measures. We evaluated the incidence of pleural adhesions found in the surgical procedure, the 
time to undertake the operation on each side, the postoperative complications, the hospital stay, and the recur-
rence rate.
At each follow-up, we recorded sweating and skin temperature at the forehead, palms of hands, axillae, abdo-
men, thighs, and soles of feet under the same temperature and humidity conditions as in baseline.
Patients graded CH  as35,47–49 1-absent, 2-mild, 3-embarrassing or moderate, 4-disabling or severe, and 
5-extreme. Grade 2 means minor and intermittent sweating in elevated temperatures or humid environments or 
during physical activity. Meanwhile, grade 3 represents intense sweating in raised temperatures or high-humidity 
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Do you need hand cream (more than before 
SEY)noitarepoeht NO 
I noce a difference in the taste of food YES NO 
Looking backwards: 




























I would recommend 
the procedure to 
another person 




























In what area of your 
body disturbs you 
most from the 
compensatory 
hyperhidrosis? 
Face Arms Axillae Chest Abdomen Back Groins Thighs
Permanent post-
operave pain YES NO 
Where? Could you describe it? 
Eyelid fall (Hörner 
syndrome) YES YES 
Have you required any surgical treatment? 
Please describe it 
Loss of strength in 
upper limbs YES NO 
Describe in what acvity 
Heart rhythm 
disturbances YES NO 
Describe when and how 





Table 1.  (continued)
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Table 1.  (continued)
The anatomical area affected by compensatory hyperhidrosis and its severity is? 
Face 1 2 2 4 5 
Hands 1 2 2 4 5 
Arms 1 2 2 4 5 
Chest 1 2 2 4 5 
Abdomen 1 2 2 4 5 
Back 1 2 2 4 5 
Buocks 1 2 2 4 5 
Groins 1 2 2 4 5 
Thighs 1 2 3 4 5 
Gustave 1 2 3 4 5 
What triggers compensatory hyperhidrosis? 
The heat 1 2 3 4 5 





1 2 3 4 5 
Emoonal 
stress 
1 2 3 4 5 
Public 
speaking 
1 2 3 4 5 
How do you adapt to compensatory hyperhidrosis? 
Do you need to do anything special? YES NO 
Do you take a shower more than once a day? YES NO 
How many mes do you have to take a shower in 
a day) 
1 2 3 or more (describe) 
Do you have to change one or more clothes once 
a day? 
YES NO 
How many mes a day do you have to change 
your clothes? 
1 2 3 or more (describe) 
Do you need to take medicaon to control the 
compensatory hyperhidrosis 
YES NO 
Under what circumstances do you need to take 





Every day or 
regularly 
What medicaon do you need to take to control 
the compensatory? Describe the drug, the dose 
and the mes you need to take it daily 
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I need to take medicaon to control the pain
occasionally 
I have to take medicaon to control the pain
regularly 
What medicaon do you need to take to 
control the pain, the dose and how many 
mes a day? 
Any addional comment you wish to make 
Paent’s signature: 
Table 1.  Postoperative quality of life scale form. A lower score indicates a better quality of life.
environments or during intensive physical activities. Lastly, grade 4 is applied when abundant sweating occurs 
even in mild climates or environments with normal humidity levels or without physical activity, bothering the 
patient and causing their clothes to get wet so that they need to change them during the day.
The patients graded dryness following the scale proposed by Lee et al.  200448 as 1-excessive dry hand, 2-dry 
hands, and 3-the same hand sweating as before the operation.
Overall patient satisfaction was measured using a five-point scale with the following grading: very unhappy, 
unhappy, dissatisfied, not completely happy, or very happy.
Quality of Life  Questionnaire40, values over 84 indicated a pretty poor quality of life, low from 69 to 84, proper 
from 36 to 51, and excellent from 20 to 35.
Primary and secondary endpoints. The primary endpoint was the prospective objective evaluation of 
CH’s incidence and severity in treating primary hyperhidrosis patients with  T3–T4 SY versus  T3–T4 RC in age- 
and sex-matched controls. In addition, we will present the results as the rate of symptom resolution and the 
degree of postoperative patient satisfaction.
The secondary endpoints evaluated the incidence of dry hands, gustatory sweating, complication rate, hospital 
stay, and recurrences of  T3–T4 SY versus  T3–T4 RC.
Ethical approval. Ethical and Research Committees approval obtained from CEIm Hospital General Uni-
versitario de Valencia, 26th of February 2016), ClinicalTrials.gov Identifier: NCT04721483.
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Statistical analysis. We performed it using the statistical software R v3.4.0. (Hornik (2020), “The R FAQ”, 
https:// cran.r- proje ct. org/ doc/ FAQ/R- FAQ. html# Citing- this- docum ent) on an Excel database (Excel, Microsoft 
Corporation, Redmond, WA, USA).
The objective was to compare the decrease in the quality of life questionnaire pre and postoperatively for 
each group.
Pre‑study. When comparing the means of two independent groups, we assumed a two-tailed problem, with 
an alpha (Type I Error) of 0.005, Power of 0.95 (Type II Error). To obtain the effect size, we assumed that the 
patient in the RY group suffered a decrease of sixty points on average, and the patients in the SY group suffered a 
reduction of fifty points on average. We also assumed that both had a similar standard deviation of around nine 
points so that the effect size was 1.11. With these assumptions, each of the arms needed at least nineteen patients. 
Adding a 10% patient power loss, at least twenty-one patients in each arm were required.
We conducted the sample size calculation using the G * Power statistical software.
Post‑study. We calculated the mean, standard deviation (SD), median, and interquartile range (IR) for the 
continuous variables. We compared the groups’ continuous variables with the t-test when values were paramet-
ric and with the Mann–Whitney U test when they were not. We calculated the percentages for each group and 
compared them with the chi-square test for the discrete variables. The level of statistical significance used was 
5% (p value < 0.05).
Results
We excluded one patient from each group because they did not attend the postoperative follow-ups.
Table 2 shows the patient’s demographic data and the baseline quality of life according to the group. Preop-
eratively there were no statistically significant differences between groups based on age, gender, comorbidities, 
Table 2.  Patients’ demographic data and baseline quality of life according to the group. The higher the figure, 
the worse is the quality of life.
Variable
Ramicotomy Sympathicotomy
p value20 (50%) 20 (50%)
Age (years)
0.949Mean (SD) 29.80 (8.41) 30.00 (10.90)
Median (IR) 30.00 (23.00–35.50) 30.00 (21.75–36.50)
Sex
0.514Men 9 (45.00%) 6 (30.00%)
Women 11 (55.00%) 14 (70.00%)
Height (centimetres)
0.084Mean (SD) 169.20 (9.37) 164.35 (7.85)
Median (IR) 168.50 (160.75–175.75) 165.00 (158.50–170.00)
Weight (kilograms)
0.476Mean (SD) 67.70 (11.69) 65.00 (12.04)
Median (IR) 66.00 (58.75–79.00) 62.00 (56.75–72.75)
BMI
0.576Mean (SD) 23.49 (2.24) 24.12 (4.50)
Median (IR) 23.56 (22.31–25.47) 23.21 (20.31–27.03)
Smoker
0.236No 14 (70.00%) 18 (90.00%)
Yes 6 (30.00%) 2 (10.00%)
Family hyperhidrosis
0.527No 11 (55.00%) 8 (40.00%)
Yes 9 (45.00%) 12 (60.00%)
Age start hyperhidrosis
0.160Mean (SD) 10.20 (7.11) 7.45 (4.75)
Median (IR) 8.50 (6.00–13.00) 6.00 (5.00–8.75)
Previous treatments
0.177
No treatment 9 (45.00%) 4 (20.00%)
Quality life baseline
0.772Mean (SD) 87.15 (6.26) 87.70 (5.63)
Median (IR) 88.00 (83.25–91.25) 88.50 (86.00–91.00)
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smoking, BMI, quality of life, sweating (Fig. 1, Supplementary table S4), and temperature (Fig. 2, Supplementary 
table S5).
Only one patient belonging to the SY group had pleural adhesions that we lysed uneventfully. No surgery 
required conversion to an open thoracotomy. We could control all intraoperative haemorrhages endoscopically.
Intraoperatively thenar eminence temperature rose more in the SY than in the RY (right hand 0.92 (SD: 0.51), 
IR: 0.50–1.20 vs. 0.51 (SD: 0.19), IR: 0.48–0.70, left hand 0.88 (SD: 0.41), IR: 0.50–1.02 vs. 0.62 (SD: 0.21, IR: 
0.48–0.80)) (Supplementary table S6). The postoperative stay was longer for the SY group (2.05, SD: 1.82 vs. 1.15, 
SD: 0.37) due to one case of hemothorax and another to pneumothorax requiring inserting a thoracic drain. The 
bleeding was controlled endoscopically during the surgical procedure, but a drain was inserted to ease blood 
removal postoperatively and shorten postoperative stay. We had no mortality and no Horner’s syndromes. The 
surgical complications only lengthened the hospital stay.
The mean follow-up is 33 months (Range: 22–44).
The following data were recorded in July, coinciding with the warmest temperatures and maximum humid-
ity. Analyzing the postoperative quality of life scale, patients undergoing SY reported worse results (49.05 (SD: 
15.66), IR: 35.50–63.00 vs. 24.30 (SD: 6.02), IR: 19.75–27.25) (Table 3). A higher figure in the quality of life scale 
means a smaller improvement postoperatively. Patients in the SY group sweated less in the hands, axillae, and 
forehead but much more in the abdomen, thighs, and feet (Fig. 3, Supplementary table S7). SY patients had a 
more significant postoperative temperature rise in the forehead, with a colder temperature in the abdomen, 
thighs, and soles of feet than those in the RY group (Fig. 4, Supplementary table S8).
We could not attribute the postoperative differences observed in sweating, temperature, and CH to BMI 
changes as we saw no statistically significant differences between the groups (SY 24.41, SD: 3.99 vs. RY 23.41, 
SD: 2.14) (Table 3).
Figure 1.  Baseline sweating from the different anatomical areas evaluated.
Figure 2.  Baseline temperatures from the different anatomical areas evaluated.
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Patients completed a postoperative form asking about the CH (Table 1), where they experienced it, where 
it bothered most, its severity, and the adopted adaptive measures. Again, results were better for the RY than for 
the SY group (Table 3).
The preoperative and postoperative July past one-year follow-up data was compared (Supplementary 
table S2). Although all patients improved, this improvement was more significant in the RY group. In addition, 
Table 3.  Postoperative quality of life and sweating changes in different anatomical areas during July. Patients 
undergoing SY reported worse results than RC ones. The higher figure in the quality of life scale means that 
there was minor improvement postoperatively. Analyzing the BMI (body mass index at the time of follow-up 
in July), we found no statistically significant differences between the groups. The CH and its consequences 
were milder in the gray rami communicantes RY than in the SY group. significance is for p <0.05
Variable
Ramicotomy Sympathicotomy
p value20 (50%) 20 (50%)
Quality life POSTOP year
 < 0.001Mean (SD) 24.30 (6.02) 49.05 (15.66)
Median (IR) 23.50 (19.75–27.25) 53.50 (35.50–63.00)
BMI postop year
Mean (SD) 23.41 (2.14) 24.41 (3.99) 0.331
Median (IR) 23.33 (22.10–24.77) 23.52 (21.82–26.17)
Shower more once a day
 < 0.001No 20 (100.00%) 7 (35.00%)
Yes 0 (0.00%) 13 (65.00%)
Change dress times days
 < 0.001
1 20 (100.00%) 6 (30.00%)
2 0 (0.00%) 8 (40.00%)
3 0 (0.00%) 6 (30.00%)
Hands too dry
0.013NO 20 (100.00%) 13 (65.00%)
YES 0 (0.00%) 7 (35.00%)
Need hand cream
0.002NO 20 (100.00%) 11 (55.00%)
YES 0 (0.00%) 9 (45.00%)
Happy result
 < 0.001
1 very unhappy 0 (0.00%) 1 (5.00%)
2 unhappy 0 (0.00%) 2 (10.00%)
3 dissatisfied 0 (0.00%) 4 (20.00%)
4 not completely happy 3 (15.00%) 11 (55.00%)
5 very happy 17 (85.00%) 2 (10.00%)
WOULD Would you have the operation again YOU HAVE THE OPERATION_AGAIN
0.002
1 I regret the operation 0 (0.00%) 1 (5.00%)
2 better not 0 (0.00%) 2 (10.00%)
3 perhaps not 0 (0.00%) 7 (35.00%)
4 yes, but with some concerns 3 (15.00%) 5 (25.00%)
5 yes, absolutely 17 (85.00%) 5 (25.00%)
RRecommend operation to somebody elseECOMEND_OPERATION TO_SOMEBODY_ELSE
 < 0.001
1 not at all 0 (0.00%) 1 (5.00%)
2 better not 0 (0.00%) 1 (5.00%)
3 perhaps not 0 (0.00%) 4 (20.00%)
4 yes but with some concerns 0 (0.00%) 7 (35.00%)
5 yes, absolutely 20 (100.00%) 7 (35.00%)
Compensatory hyperhidrosisCOMPENSATORY_HYPERHIDROSIS
 < 0.001
1 No 17 (85.00%) 1 (5.00%)
2 intermittent or minor 3 (15.00%) 0 (0.00%)
3 embarrassing 0 (0.00%) 2 (10.00%)
4 disabling 0 (0.00%) 4 (20.00%)
5 severe 0 (0.00%) 13 (65.00%)
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the temperature changes were milder for the RY group than the SY patients (Supplementary table S3). These 
temperature changes attest to a milder sympathetic lesion for the first than for the second group.
Patients have reported no recurrences at this time, with a maximum follow-up of 4 years.
Discussion
Ever since the introduction of TS in the treatment of palmar and axillary HH, there has been a continuous quest 
to find a way to reduce its most unpleasant side effect:  CH24. Following the idea of minimizing the surgically 
induced damage to the sympathetic chain  Wittmoser34 introduced in 1992 RY’s technique. It entailed the selec-
tive lesion of the rami communicantes, both white and gray, from  T2 to  T4 ±  T5. The procedure ended with the 
sympathetic chain’s elevation from its bed to ascertain that no rami communicantes, either gray or white, were 
left intact. This surgical technique was not as selective as expected because it damaged the sympathetic input for 
the lungs and heart and the head and  face34. Wittmoser described this surgical technique but did not undertake 
Figure 3.  Postoperative sweating in different anatomical areas. Please notice some residual sweating in the 
partially sympathetically denervated areas in the RY, while there is almost none in the sympathicotomy. In 
addition, there is an increase in sweating in the abdomen, thighs, and feet in this last group that does not happen 
in the first group.
Figure 4.  Postoperative temperature of the different anatomical areas. We see a more significant drop in the 
abdomen, thighs, and feet in the sympathicotomy group, attesting that they suffer from a more substantial CH. 
Also, notice that the temperature rises more in the forehead, hands, and axillae, showing that the sympathetic 
denervation is more prominent in the sympathicotomy group.
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any clinical trial and never published any results.  Gossot35 in 1997 reported his results in 62 patients in whom he 
lesioned the  T2 to  T4 ±  T5 gray and the white rami communicantes with the elevation of the sympathetic chain. 
He compared this technique with the SY of the same ganglia in fifty-four patients. He found that CH’s incidence 
was the same in both groups, but the severity was less in the RY than in the SY group. However, the recurrence 
rate was more prominent in the first than in the second group (5% RY vs. 0% SY). This increase in the recur-
rence rate was a deterrent for spreading this surgical technique of grey and white rami communicantes lesion. 
Nevertheless, this study showed that lesser sympathetic denervation meant that the hands’ palms could retain 
residual  sweating35. Other researchers have confirmed these  results48,50 (Table 4).
In the following years, more studies compared the SY with the RY, confirming that RY has a lower incidence 
of  CH15,47,48,50–52, with less dry  hands47,48,50,52 but with some  recurrences15,48,50. The technique used to perform the 
RY kept being the section of both the gray and white rami communicantes with the sympathetic chain’s elevation. 
On further analysis of this group of publications, we realize that the number of levels treated is not uniform. 
Two of them include the rami communicantes of the  T2  ganglion15,47. Nowadays, we know that lesioning this 
ganglion should be avoided as it correlates with a more severe  CH14,18,26,53–55. In three other studies, only the rami 
communicantes of the  T3 ganglion are  sectioned48,50,51. These studies report the most significant recurrence rate 
(8.848 and 21.4%50). In one study, researchers reported  T2 and  T3 gray and white rami communicantes lesions 
with the sympathetic chain’s  elevation15. The researchers in this group say an incidence of CH of 23.07% and a 
recurrence rate of 15.38%. Lesion of  T3 and  T4 gray and white rami communicantes had an incidence of CH of 
10.9% and no recurrence. In conclusion, the recommendation is to avoid  T2 lesions and damage only  T3 and  T4.
In a step forward, Coveliers et al.37 lesioned only the  T2–T4 gray rami communicantes not touching the 
sympathetic chain nor the white rami communicantes. The incidence of CH dropped to 7.2%, and they do not 
report any recurrence. Akil et al.36 reported the lesion of the  T2–T5 gray rami communicantes with no CH and 
no recurrences. HH’s rate of control ranges from 96%37 to 100%36. Both studies entail a more extensive lesion, 
including  T236,37 and one of those studies,  T536. There is an agreement in many previous reports to avoid lesioning 
 T2 to reduce the incidence and severity of  CH14,18,26,53,55,56.
Table 4.  Summary of the studies on endoscopic thoracic RY over the years. Sympathicotomy (SY). 
Ramicotomy (RY). Sch (Sch) Compensatory sweating (CH). Gustatory sweating (GS). Persistent hand 
humidity (PHH). Recurrence hyperhidrosis (RH). Not described (ND). Phone (follow-up performed through 
a telephone questionnaire).















–/100 –/0 ND ND ND ND









–/96 –/7.2 –/1.8 ND ND ND 24 mo (3–36 months) ND
Hwang et al 2013 46/43
T3 SY/T3–T4 
gray + white 
rami lesion 
Sch lifted
97.8/83.7 37.2/10.9severe in 14/8.7 ND 82.6/25.6 15.2/58.5 ND
At 
1 month + phone 
1-year
79.1/91.3
Lee et al 2004 64/83
T2 SY/T3 
Gray + white 
rami lesion 
Sch lifted
93.8/69.9 43.3/15.5 ND 6.2/18.1 6.25/30.1 0/8.8 Phone 9.7 ± 1.3 vs 6.6 ± 3.7 months 78.1/68.6
Kim et al 2004 22/22
T2 clip/T2 
gray + white 
rami lesion 
Sch lifted
ND 75.5/36.4 4.4/0 22.7/13.6 0/18.3 ND Phone 20.1 ± 7.7 vs 10.8 ± 2.0 mo 77.3/63.6
Lee et al 2003 40/68
T3 clip/T3 
gray + white 
rami lesion 
Sch lifted
90/67.6 94.1/67.4 ND ND 8.9/23.5 ND Phone 6.6 ± 3.7 vs 28.2 ± 6.2 mo 82.5/67.6
Cho et al 2003 13/13 T3 clip/T3 RY technique ND ND 92.9/54.5 ND
SY only % 1.4 
out of 4
RY only % 2 
out of 4 6.7/21.4 ND
5.5/6.5 out 
of 10
Cheng et al 2001 34/13
T2–T3 SY/T2–
T3 gray + white 
lesion Sch 
lifted
ND 82/23.07 ND ND ND 0/15.38 Mean 9 mo ND
Gossot et al 1997 54/62
T2–T4 ±  T5 SY/
T2–T4 ±  T5 
gray + white 
rami lesion 
Sch lifted
100/100 50/21 ND ND ND 0/5 Mean 11 mo ND
Wittmoser 
et al 1992 –/–
T2–T4 ±  T5 
gray + white 
rami lesion
NA NA NA NA NA NA NA NA
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Table 4 summarizes the results of all the research groups involved over the years with RY.
The first problem with analyzing all these research groups is that they report CH’s incidence and severity based 
on the patients’ subjective  report15,35–37,47,48,51,52. Some researchers report discrepancies between subjective percep-
tion and the objective measurement of hyperhidrosis and  CH57,58. Moreover, different patients react differently to 
the same degree of residual or new  sweating59,60. The oldest method to measure sweat production, the Quinizarin 
sweat test, is inaccurate 61,62. Gravimetry is more objective but still far from ideal. It entails giving a pre-weighted 
tissue, cotton swab, or piece of filter paper to the patient and asking them to wipe the area under investigation 
for 1 min in a room with temperature 24–25 °C and humidity 15–17%. Then, the investigator weighs the tissue, 
cotton swab, or piece of filter paper again, and the increase in weight gives the amount of sweat in  milligrams63–65. 
This technique of sweat measurement did not seem accurate enough for our study. The most objective method 
is the VapoMeter® closed-chamber device (Delfin Technologies Ltd, Kuopio, Finland)66,67. The problem is that 
it only analyzes a tiny skin area (about 2.5 cm in diameter) at a time. Our study measured sweat production in 
milligrams of water recovered from an absorbent pad and temperature changes measured in degrees Celsius.
The second drawback is that in all the studies, the researchers did the follow-up through  telephone36,47,48,51,52 
or  email36 questionnaires, which could be insufficient for objective assessment of the percentage and severity 
of CH. For this reason, our study exclusively used face-to-to-face follow-ups in our out-patients Department.
In our study, all the SY patients and the RY groups got complete relief from the palmar HH. The  T3–T4 gray 
rami communicantes RY has shown much better results than SY levels concerning CH, dry hands, and patient 
satisfaction. Although the surgical time is somewhat longer in RY than in the SY group, this extra time seems 
warranted to achieve better results. No mortalities or severe complications happened in any group, besides one 
case of pneumothorax and another of hemothorax. Hence the quality of the result must guide our decision when 
using one surgical technique or the other. The lesion of  T2 and  T5 gray rami communicantes, practised by other 
 researchers36,37, does not seem  justified18,28,29.
An additional advantage is that the gray rami communicantes RY leaves some residual sweating in the 
hands. Former studies involving gray and white rami communicantes lesions already reported this residual 
hand  moisture47,48,51,52. However, researchers make no comments on this particular issue in the only two reports 
involving only the gray rami communicantes lesion 36,37. In our study, the need for a hand cream to combat 
postoperative hand dryness is present in 45% of the SY group patients and none of the RY patients (Table 3). 
This need for hand cream shows that postoperatively the hands are less dry in the RY than in the SY group.
Limitations
Our study’s limitations are the reduced number of patients in each group and the need to gather more long-term 
data, particularly on possible H.H. recurrences.
Strengths
It is a prospective randomized study. A third party recorded the data, and the follow-ups were done by attending 
patients face-to-face and not through telephone or email questionnaires.
Conclusions
Compared with  T3–T4 SY,  T3–T4 gray RY shows better results. In addition, patients suffer from less CH and 
manifest greater satisfaction. Therefore, a more extensive RY does not seem necessary.
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